Real-time enrollment status for this leptomeningeal metastases clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:02 PM UTC
| NCT Number | NCT05184816 |
| Recruiting Status | Recruiting |
| Condition | Leptomeningeal Metastases |
| Phase | PHASE1 |
| Target Enrollment | 32 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | July 14, 2026 (Jul 14, 2026) |
As of October 12, 2026: Clinical trial NCT05184816 is currently recruiting participants. This phase1 study for leptomeningeal metastases is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05184816 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05184816 was last updated Jul 14, 2026 (July 14, 2026). HelloStudys verifies this status automatically.